Interim Analysis of Impact of Adding Low Dose Pulmonary Radiotherapy to Moderate COVID-19 Pneumonia Patients: IMpaCt-RT Study

Pritanjali Singh(All India Institute of Medical Sciences), Alok Ranjan(All India Institute of Medical Sciences), Deependra Kumar(All India Institute of Medical Sciences), Bithika Modak(All India Institute of Medical Sciences), Amrita Rakesh(All India Institute of Medical Sciences), Priya Kakoty(All India Institute of Medical Sciences), Avik Mandal(All India Institute of Medical Sciences), Dharmendra Singh(Advanced Materials and Processes Research Institute), Rohit Saini(All India Institute of Medical Sciences), Anindya Kumar Baral(All India Institute of Medical Sciences), Divendu Bhushan(All India Institute of Medical Sciences), Subhash Kumar(All India Institute of Medical Sciences Raipur), Ashwin Thovarayi(All India Institute of Medical Sciences), Abhishek Shankar(DR. B.R.A. Institute Rotary Cancer Hospital), Arkaprava Sinha(All India Institute of Medical Sciences), Rajhans Kumar(All India Institute of Medical Sciences), Samyak Chauhan(All India Institute of Medical Sciences), Rakesh Ranjan(All India Institute of Medical Sciences), Arijit Saha(All India Institute of Medical Sciences), Manika Verma(All India Institute of Medical Sciences), Amarjeet Kumar(Babasaheb Bhimrao Ambedkar Bihar University)
Frontiers in Oncology
March 29, 2022
Cited by 7


Related Papers